V. Warren

发表

Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a.

M. Bednarek, L. V. D. van der Ploeg, A. Howard, 2000, Journal of medicinal chemistry.

Imidazopyridines: a novel class of hNav1.7 channel blockers.

V. Warren, K. Lyons, G. Kaczorowski, 2008, Bioorganic & medicinal chemistry letters.

Type III omega-agatoxins: a family of probes for similar binding sites on L- and N-type calcium channels.

P. Griffin, M. Adams, V. Warren, 1994, Biochemistry.

ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels.

K. Blumenthal, V. Warren, B. Priest, 2007, Toxicon : official journal of the International Society on Toxinology.

Properties of Three Baculovirus-Expressing Genes That Encode Insect-Selective Toxins: μ-Aga-IV, As II, and Sh I

J. Warmke, V. Warren, Peiyi Wang, 1996 .

Microsoft Word-56059911-file00

Haedo, O. McManus, S. Arneric, 2011 .

A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain.

V. Warren, K. Lyons, G. Kaczorowski, 2013, Bioorganic & medicinal chemistry letters.

Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile Sulfonamide.

O. McManus, A. Swensen, J. Herrington, 2013, ACS medicinal chemistry letters.

A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of pain.

O. McManus, A. Swensen, J. Herrington, 2011, Bioorganic & medicinal chemistry letters.

Substituted biaryl pyrazoles as sodium channel blockers.

V. Warren, Sanjeev Kumar, M. Fisher, 2010, Bioorganic & medicinal chemistry letters.

Discovery of a novel class of biphenyl pyrazole sodium channel blockers for treatment of neuropathic pain.

V. Warren, Sanjeev Kumar, M. Fisher, 2010, Bioorganic & medicinal chemistry letters.

Benzazepinone Nav1.7 blockers: potential treatments for neuropathic pain.

D. Macintyre, V. Warren, K. Lyons, 2007, Bioorganic & medicinal chemistry letters.

Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.

D. Macintyre, V. Warren, M. Fisher, 2007, Bioorganic & medicinal chemistry letters.

Nodulisporic acid opens insect glutamate-gated chloride channels: identification of a new high affinity modulator.

D. Schmatz, J. Schaeffer, V. Warren, 2000, Biochemistry.

Two tarantula peptides inhibit activation of multiple sodium channels.

V. Garsky, M. Bogusky, V. Warren, 2002, Biochemistry.

Ivermectin and nodulisporic acid receptors in Drosophila melanogaster contain both gamma-aminobutyric acid-gated Rdl and glutamate-gated GluCl alpha chloride channel subunits.

D. Cully, D. Dean, V. Warren, 2002, Biochemistry.

A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain model.

V. Warren, Y. S. Tang, K. Wafford, 2004, Biochemistry.

Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists.

G. Ghai, V. Warren, W. D. Cash, 1988, Journal of medicinal chemistry.

Effects of simultaneous expression of two sodium channel toxin genes on the properties of baculoviruses as biopesticides

V. Garsky, J. Warmke, V. Warren, 1998 .

Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretion.

O. McManus, V. Garsky, Yun-ping Zhou, 2006, Diabetes.

Analgesic Effects of a Substituted N-Triazole Oxindole (TROX-1), a State-Dependent, Voltage-Gated Calcium Channel 2 Blocker

Clare London, Joseph L Duffy, Owen B McManus, 2010, Journal of Pharmacology and Experimental Therapeutics.

A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors.

O. McManus, Mark E. Williams, A. Swensen, 2008, Assay and drug development technologies.

Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyes.

V. Warren, G. Kaczorowski, B. Priest, 2004, Assay and drug development technologies.

Characterization of the Substituted N-Triazole Oxindole TROX-1, a Small-Molecule, State-Dependent Inhibitor of Cav2 Calcium Channels

Rodolfo J. Haedo, David Parker, Clare London, 2012, Molecular Pharmacology.

WIN 17317-3, a new high-affinity probe for voltage-gated sodium channels.

V. Warren, G. Kaczorowski, H. Glossmann, 1999, Biochemistry.

Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers.

V. Warren, Sanjeev Kumar, M. Fisher, 2010, Bioorganic & medicinal chemistry letters.

3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activity.

V. Warren, M. Fisher, K. Lyons, 2008, Bioorganic & medicinal chemistry letters.

Analgesic Effects of a Substituted N-Triazole Oxindole (TROX-1), a State-Dependent, Voltage-Gated Calcium Channel 2 Blocker

O. McManus, S. Arneric, A. Swensen, 2010, Journal of Pharmacology and Experimental Therapeutics.

Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.

O. McManus, A. Swensen, J. Herrington, 2012, Journal of medicinal chemistry.